Clinical features of the porphyrias (Q41745501)

8 October 2017

1 reference

title

Clinical features of the porphyrias (English)

1 reference

8 October 2017

Poh-Fitzpatrick MB

1

1 reference

8 October 2017

publication date

1 March 1998

1 reference

8 October 2017

published in

Clinics in Dermatology

1 reference

8 October 2017

volume

16

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

251-264

1 reference

Cutaneous changes in the porphyrias. A microscopic study

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Electron microscopy of the skin in erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Histochemical and electron microscopical study of the bulla from porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Location of basement membrane type IV collagen beneath subepidermal bullous diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Erythropoietic Protoporphyria: Lipid Peroxidation and Red Cell Membrane Damage Associated with Photohemolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Photodynamic damage of the erythrocyte membrane caused by protoporphyrin in protoporphyria and in normal red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Cholesterol Hydroperoxide Formation in Red Cell Membranes and Photohemolysis in Erythropoietic Protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Reactivity of singlet molecular oxygen with cholesterol in a phospholipid membrane matrix. A model for oxidative damage of membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Porphyrins and related compounds as photodynamic sensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Photodynamic modification of proteins in human red blood cell membranes, induced by protoporphyrin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Photooxidation of the protoporphyrin-apomyoglobin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Photodynamic action of protoporphyrin IX on human erythrocytes: cross-linking of membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Photodynamic effects of protoporphyrin on human erythrocytes. Nature of the cross-linking of membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

On the mode of cytotoxic action of photoactivated porphyrins

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Mechanism of in vitro photohemiolysis in erythropoietic protoporphyria (EPP)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Protoporphyrin-induced photohemolysis in protoporphyria and in normal red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Photoreactions associated with in vitro hemolysis in erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Protective action of beta-carotene against lethal photosensitization of fibroblasts in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Role of lysosomes and of cell membranes in photosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Photosensitization and Lysosomal Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Erythropoietic protoporphyria-submicroscopic events during the acute photosensitivity flare

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Photoradiation Therapy. II. Cure of Animal Tumors With Hematoporphyrin and Light23

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Primary mechanisms of erythrocyte photolysis induced by biological sensitizers and phototoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

In vitro studies on the protoporphyrin uptake and photosensitivity of normal skin fibroblasts and fibroblasts from patients with erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

A health survey of workers in a 2,4-D and 2,4,5-T plan with special attention to chloracne, porphyria cutanea tarda, and psychologic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Porphyria cutanea tarda and antibodies to hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Porphyria cutanea tarda associated with human immunodeficiency virus infection. A study of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Hepatoerythropoietic porphyria: a variant of childhood-onset porphyria cutanea tarda. Porphyrin profiles and enzymatic studies of two cases in a family

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Hepatoerythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Hepato-erythropoietic porphyria presenting as scleroderma and acrosclerosis in a sibling pair

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of isocoproporphyrin in faeces

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Juvenile acute intermittent porphyria with hypercholesterolemia and epilepsy: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Drug therapy in the acute porphyrias

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

The acute attack of porphyria.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

The primary enzyme defect in hereditary coproporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Homozygous case of hereditary coproporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Harderoporphyria: a variant hereditary coproporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Harderoporphyrin coproporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

The enzymatic defect in variegate prophyria. Studies with human cultured skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

HOMOZYGOUS VARIEGATE PORPHYRIA

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Homozygous variegate porphyria: two similar cases in unrelated families.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Homozygous variegate porphyria. A severe skin disease of infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Homozygous variegate porphyria: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Congenital erythropoietic porphyria. A mild variant with low uroporphyrin I levels due to a missense mutation (A66V) encoding residual uroporphyrinogen III synthase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Biochemical diagnosis of a fatal case of Günther's disease in a newborn with hydrops foetalis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Congenital erythropoietic porphyria: clinical, biochemical, and enzymatic profile of a severely affected infant

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Late onset erythropoietic porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Bone-marrow transplantation for congenital erythropoietic porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Studies in porphyria: functional evidence for a partial deficiency of ferrochelatase activity in mitogen-stimulated lymphocytes from patients with erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Human Erythropoietic Protoporphyria: Two point mutations in the ferrochelatase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Recessive inheritance of erythropoietic protoporphyria with liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Genetic aspects of erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Erythropoietic protoporphyria 10 years experience

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Protoporphyrin metabolic balance in human protoporphyria.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Erythropoietic protoporphyria: evidence for multiple sites of excess protoporphyrin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Isotopic Studies of the Erythropoietic and Hepatic Components of Congenital Porphyria and ‘Erythropoietic’ Protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

The liver in protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

`Erythropoietic' protoporphyria and cirrhosis in sisters

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Hepatic disease in erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Recessive inheritance of erythropoietic protoporphyria with liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Ferrochelatase structural mutant (Fechm1Pas) in the house mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

The "priming phenomenon" in the acute phototoxicity of erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Activation of the complement system in patients with porphyrias after irradiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Human protoporphyria: reduced cutaneous photosensitivity and lower erythrocyte porphyrin levels during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Anemia in Erythropoietic Protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Evidence for neurological dysfunction in end-stage protoporphyric liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Liver transplantation in a patient with protoporphyria.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Hepatobiliary implications and complications in protoporphyria, a 20-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Blood exchange and transfusion therapy for acute cholestasis in protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Transfusion therapy for erythropoietic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Repression by Hematin of Porphyrin Biosynthesis in Erythrocyte Precursors in Congenital Erythropoietic Porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Effect of hematin administration to patients with protoporphyria and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Porphyrin-binding effect of cholestyramine. Results of in-vitro and in-vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

Chenodeoxycholic acid therapy in erythrohepatic protoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900205-8

7 January 2021

10.1016/S0738-081X(97)00205-8

Identifiers

DOI

1 reference

8 October 2017

1 reference